Constitution Capital’s AbbVie ABBV Stock Holding History

Constitution Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$201K	Sell	800 -200	-20%	-$43K	0.1%	62
2026 Q1	$217K	Sell	1,000 -500	-33%	-$111K	0.11%	59
2025 Q4	$343K	Hold	1,500	–	–	0.16%	49
2025 Q3	$347K	Buy	+1,500	New	+$305K	0.16%	49
2025 Q2	–	Sell	-1,000	Closed	-$210K	–	57
2025 Q1	$210K	Buy	+1,000	New	+$194K	0.12%	58
2024 Q1	–	Sell	-2,500	Closed	-$387K	–	61
2023 Q4	$387K	Sell	2,500 -500	-17%	-$72.9K	0.23%	40
2023 Q3	$447K	Hold	3,000	–	–	0.3%	38
2023 Q2	$404K	Hold	3,000	–	–	0.23%	45
2023 Q1	$478K	Sell	3,000 -100	-3%	-$15.3K	0.29%	42
2022 Q4	$501K	Buy	3,100 +400	+15%	+$61.3K	0.31%	41
2022 Q3	$362K	Buy	2,700 +600	+29%	+$86.1K	0.24%	43
2022 Q2	$322K	Hold	2,100	–	–	0.21%	44
2022 Q1	$340K	Buy	2,100 +400	+24%	+$58.1K	0.19%	43
2021 Q4	$230K	Buy	+1,700	New	+$201K	0.12%	59

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Constitution Capital's ABBV Position: Q2 2026 in Review

Constitution Capital reduced its AbbVie (ABBV) stake by 20% in Q2 2026, selling an estimated $43K and leaving 800 shares worth $201K. The position accounts for 0.1% of the portfolio, ranked #62.

Constitution Capital first reported a position in ABBV in Q4 2021 and has held it in 14 quarters since. The position peaked at $501K in Q4 2022. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Constitution Capital held 800 shares of AbbVie worth $201K as of Q2 2026.
Constitution Capital sold 200 AbbVie shares in Q2 2026, an estimated $43K.
AbbVie made up 0.1% of Constitution Capital's portfolio in Q2 2026, its #62 holding.
Constitution Capital first reported a position in AbbVie in Q4 2021 and has held it in 14 quarters since.
Constitution Capital's AbbVie position peaked at $501K in Q4 2022.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Constitution Capital's 13F filing for Q2 2026, filed 9 Jul 2026.